Effect of enprostil on omeprazole-induced hypergastrinemia and inhibition of gastric acid secretion in peptic ulcer patients

Digestive Diseases and Sciences

Volumn 42, Issue 8, 1997, Pages 1741-1746

  Tari, Akira ^a   Hamada, Masanori ^b   Kamiyasu, Toshiki ^b   Sumii, Koji ^b   Haruma, Ken ^b   Inoue, Masaki ^b   Kishimoto, Shinya ^b   Kajiyama, Goro ^b   Walsh, John H ^b  

^a ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^b NONE

Author keywords

Enprostil; Helicobacter pylori; Hypergastrinemia; Intragastric pH measurement; Omeprazole

Indexed keywords

ENPROSTIL; GASTRIN; OMEPRAZOLE; PROSTAGLANDIN E;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM ULCER; FEMALE; GASTRIN BLOOD LEVEL; HELICOBACTER PYLORI; HUMAN; HYPERGASTRINEMIA; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STOMACH ACID SECRETION; STOMACH PH; STOMACH ULCER;

ADULT; AGED; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; ENPROSTIL; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER;

EID: 0030875754     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018825902055     Document Type: Article

References (47)

1. Blum AL: Treatment of acid-related disorders with gastric acid inhibitors: the state of the art. Digestion 47(suppl 1):3-10, 1990
2. Walsh JH, Richardson CT, Fordtran JS: pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 55:462-468, 1975
3. Lind T, Cederberg C, Forssell H, Olausson M, Olbe L: Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment. Scand J Gastroenterol 23:1259-1266, 1988
4. Selway SAM: Potential hazards of long-term acid suppression. Scand J Gastroenterol 25(suppl 178):85-92, 1990
5. Buchanan N, Laferla G, Hearns J, Buchanan KD, Crean GP, McColl KEL: Effect of a single oral dose of enprostil on gastric secretion and gastrin release. Am J Med 81(2A):40-43, 1986
6. Roszkowski AP, Garay GL, Baker S, Schuler M, Carter H: Gastric antisecretory and antiulcer properties of enprostil, (±)-11α,15α-dihydroxy-16-phenoxy-17, 18, 19, 20-tetranor-9-oxoprosta-4,5,13(t)-trienoic acid methyl ester. J Pharmacol Exp Ther 239:382-389, 1986
7. 2) on gastric acidity and serum gastrin concentration in normal subjects. Gastroenterology 86:1058, 1984
8. Crobach LFSJ, Jansen JBMJ, Lamers CBHW: Effect of enprostil on basal and postprandial serum gastrin levels in patients with antral G-cell hyperfunction, Zollinger-Ellison syndrome and normal subjects. Gut 27:A1282, 1986
9. Walsh JH: Role of gastrin as a trophic hormone. Digestion 47(suppl 1):11-16, 1990
10. Watson SA, Durrant LG, Morris DL: Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitro. Br J Surg 75:342-345, 1988
11. +-ATPase activity by omeprazole promotes degradation and production of parietal cells. Am J Physiol 266:G745-G758, 1994
12. Warren JR, Marshall BJ: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273-1275, 1983
13. Blaser MJ: Gastric Campylobacter-like organisms, gastritis and peptic ulcer disease. Gastroenterology 93:371-383, 1987
14. McKinlay AW, Upadhyay R, Gemmell CG, Russell RI: Helicobacter pylori bridging the credibility gap. Gut 31:940-945, 1990
15. Haruma K, Okamoto S, Sumii K, Yoshihara M, Tari A, Teshima H, Shimamoto T, Takahara Y, Tanaka S, Yamamoto G, Teixeira CR, Sumii M, Kishimoto S, Kajiyama G, Wagner S: Helicobacter pylori infection and gastroduodenal disease: A comparison of endoscopic findings, histology, and urease test data. Hiroshima J Med Sci 41:65-70, 1992
16. Smith JTL, Pounder RE, Nwokolo CU, Lanzon-Miller S, Evans DG, Graham DY, Evans DJ: Inappropriate hypergastrinemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 31:522-525, 1990
17. Chittajallu RS, Neithercut WD, Macdonald AMI, McColl KEL: Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentrations. Gut 32:21-24, 1991
18. Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J: Campylobacter pylori and duodenal ulcers: The gastrin link. Lancet 1:1167-1168, 1989
19. +-ATPase α-subunit mRNA by omeprazole. Biochim Biophys Acta 1129:49-56, 1991
20. +-ATPase α-subunit induced by omeprazole. Am J Physiol 265:G752-G758, 1993
21. +-ATPase α-subunit expression. Am J Physiol 266:G444-G450, 1993
22. Rao SSC, Nayak KS, Swarnalata G, Goyal DN, Prasad Rao KP, Mitros FA: Gastric carcinoid associated with ranitidine in a patient with renal failure. Am J Gastroenterol 88:1273-1274, 1993
23. Cadiot G, Lehy T, Ruszniewski P, Bonfils S, Mignon M: Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Dig Dis Sci 38:1307-1317, 1993
24. Graham DY, Opekun A, Lew GM, Evans DJ, Klein PFD, Evans DG: Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 85:394-398, 1990
25. Graham DY, Opekun A, Lew GM, Klein PD, Walsh JH: Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gastroenterology 100:1571-1575, 1991
26. Levi S, Beardshall K, Sewift I, Foulkes W, Playford R, Ghosh P, Calam J: Antral Helicobacter pylori, hypergastrinemia, and duodenal ulcers: effect of eradicating the organism. Br Med J 299:1504-1505, 1989
27. Oderda G, Vaira D, Holton J, Ainley C, Altare F, Ansaldi N: Amocycillin plus tinidazole for Campylobacter pylori gastritis in children: Assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet 1:690-692, 1989.
28. Chittajallu RS, Dorrian CA, Ardill JES, McColl KEL: Effect of Helicobacter pylori on serum pepsinogen 1 and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol 27:20-24, 1992
29. Moss SF, Calam J: Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: Effect of eradication of Helicobacter pylori. Gut 34:888-892, 1993
30. El-Omar E, Penman I, Dorrian CA, Ardill JES, McColl KEL: Eradicating Hylicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 34:1060-1065, 1993
31. Wagner S, Haruma K, Gladziwa U, Soudali B, Gebel M, Bleck J, Schmidt H, Manns M: Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: Significance of inflammation and effect of bacterial eradication. Am J Gastroenterol 89:1211-1218, 1994
32. Moss SF, Legon S, Bishop AE, Polak JM, Calam J: Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340:930-932, 1992
33. Sumii M, Sumii K, Tari A, Kawaguchi H, Yamamoto G, Takehara Y, Fukino Y, Kamiyasu T, Hamada M, Tsuda T, Yoshihara M, Haruma K, Kajiyama G: Expression of antral gastrin and somatostatin mRNA in Helicobacter pylori-infected subjects. Am J Gastroenlerol 89:1515-1519, 1994
34. Katelaris PH, Scow F, Lin BPC, Napoli J, Ngu MC, Jones DB: Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 34:1032-1037, 1993
35. Goldschmiedt M, Karnes WE, Feldman M: Relationship between Helicobacter pylori (HP) and gastric acid secretion/serum gastrin concentrations in healthy human. Gastroenterology 98:A92, 1990
36. Smith JTL, Pounder RE, Nwokolo CU, Lanzon-Miller S, Evans DG, Graham DY, Evans DJ: Inappropriate hypergastrinemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 31:522-525, 1990
37. Wagner S, Gladziwa U, Haruma K, Varrentrapp M, Gebel M: Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcer. Gut 33:1024-1028, 1992
38. Mullin GE, Kalloo AN: Does Helicobacter pylori infection affect gastric acid secretion? Gastroenterology 98:A92, 1990
39. Moss SF, Calam J: Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: Effect of eradication of Helicobacter pylori. Gut 34:888-892, 1993
40. Brady CE III, Hadfield TL, Hyatt JR, Utts SJ: Acid secretion and serum gastrin levels in individuals with Campylobacter pylori. Gastroenterology 98:923-927, 1988
41. Hui W-M, Lam S-K, Chau P-Y, Ho J, Lui I, Lai C-L, Lok A S-F, Ng M M-T: Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis. Dig Dis Sci 32:1255-1260, 1987
42. Kang JY, Wee A: Helicobacter pylori and gastric acid output in peptic ulcer disease. Dig Dis Sci 36:5-9, 1991
43. 14C]aminopyrine accumulation and cyclic AMP generation by isolated canine parietal cells. J Clin Invest 65:1222-1229, 1980
44. Soll AH, Chen MCY, Amirian DA, Toomey M, Alvarez R: Prostanoid inhibition of canine parietal cells. Am J Med 81(2A):5-11, 1986
45. Schepp W, Chan CB, Giraud AS, Avedian D, Chen MCY, Chew P, Walsh JH, Soll AH: Effects of prostaglandins on gastrin release from canine antral mucosal cells in primary cultere. Am J Physiol 266:G194-G200, 1994
46. Soll AH, Whittle BJR: Prostacyclin analogues inhibit canine parietal cell activity and cyclic AMP formation. Prostaglandins 21:353-365, 1981
47. Ding M, Kinoshita Y, Kishi K, Nakata H, Hassan S, Kawanami C, Sugimoto Y, Katsuyama M, Negishi M, Narumiya S, Ichikawa A, Chiba T: Distribution of prostaglandin E receptors in the rat gastrointestinal tract. Prostaglandins (in press)